Large-scale testing (Phase 3)WithdrawnNCT04637282
What this trial is testing
Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3
Who this might be right for
Juvenile Neuronal Ceroid Lipofuscinosis
Polaryx Therapeutics, Inc.
Showing 2 of 0 results